Althera Laboratories Press Releases - EIN Presswire - Press Release Distribution Service

Published on February 10, 2026 - 11:03 GMT

Althera Laboratories Receives Positive Outcome in Decentralized Procedure for Alrofen® (Rosuvastatin/Fenofibrate) in EU

Innovative Fixed-Dose Combination Recommended for Approval for the Treatment of Mixed Dyslipidaemia DUBLIN, DUBLIN, IRELAND, February 10, 2026 /⁨EINPresswire.com⁩/ -- Althera Laboratories announces it has received a positive recommendation from the Dutch …

Distribution channels: Business & Economy, Companies ...

Published on January 30, 2026 - 12:27 GMT

Althera and Bruno Farmaceutici Sign Strategic Licensing Agreement to Bring Advanced Type 2 Diabetes Therapy to Italy

Partnership leverages Bruno Farmaceutici’s robust commercial leadership to launch Althera’s innovative Type 2 Diabetes combination therapy DUBLIN, DUBLIN, IRELAND, January 30, 2026 /⁨EINPresswire.com⁩/ -- Althera Laboratories Limited, a global …

Distribution channels: Business & Economy, Companies ...

Published on December 3, 2025 - 06:00 GMT

Althera Laboratories and Tabuk Pharmaceuticals Announce Strategic Partnership for Advanced T2D Therapy in MENA

Partnership leverages Tabuk’s extensive regional leadership to broaden access to Althera’s innovative Type 2 Diabetes combination therapy DUBLIN, DUBLIN, IRELAND, December 3, 2025 /⁨EINPresswire.com⁩/ -- Althera Laboratories Limited, a global …

Distribution channels: Chemical Industry, Companies ...

Published on September 9, 2025 - 05:59 GMT

Althera Laboratories Announces GMP Approval of State-of-the-Art Pharmaceutical Manufacturing Facility

New facility in Mysuru, India, set to produce one billion oral doses annually, strengthening Althera’s supply chain for cardiovascular and metabolic medicines. DUBLIN, DUBLIN, IRELAND, September 9, 2025 /⁨EINPresswire.com⁩/ -- Althera Laboratories Limited …

Distribution channels: Business & Economy, Chemical Industry ...

Published on August 6, 2025 - 08:07 GMT

New Agreement Brings Breakthrough Dyslipidemia Treatment to Saudi Arabia and MEA

Strategic partnership between Jamjoom Pharma and Althera Laboratories will bring an innovative, dual-action cholesterol therapy to the region. DUBLIN, DUBLIN, IRELAND, August 6, 2025 /⁨EINPresswire.com⁩/ -- Jamjoom Pharma, a leading Saudi pharmaceutical …

Distribution channels: Business & Economy, Companies ...

Published on June 23, 2025 - 11:24 GMT

Althera Laboratories Reinforces Commitment to Emerging Markets with Presence at CPHI South East Asia 2025

Company to showcase innovative cardiometabolic pipeline at Booth N16 in Kuala Lumpur. DUBLIN, DUBLIN, IRELAND, June 23, 2025 /⁨EINPresswire.com⁩/ -- Althera Laboratories, a pharmaceutical company focused on developing value-added medicines for …

Distribution channels: Business & Economy, Conferences & Trade Fairs ...

Published on June 10, 2025 - 08:24 GMT

Althera Laboratories Expands into Heart Failure, Unveils Advanced Triple-Combination Therapies for Global Licensing

Pioneering Triple-Combination Therapies for Heart Failure Now Available for Global Licensing DUBLIN, DUBLIN, IRELAND, June 10, 2025 /⁨EINPresswire.com⁩/ -- Althera Laboratories, a pharmaceutical company leveraging its deep expertise in cardiovascular and …

Distribution channels: Business & Economy, Companies ...